JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Sessa Capital (Master), L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned agree, as of February 16, 2021, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Xeris Pharmaceuticals, Inc., and such statement to which this Joint Filing Agreement is attached as Exhibit 1 is filed on behalf of each of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Sessa Capital (Master), L.P. • Chemicals & allied products
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned agree, as of March 23, 2020, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of The Chemours Company, and such statement to which this Joint Filing Agreement is attached as Exhibit 1 is filed on behalf of each of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • July 11th, 2022 • Sessa Capital (Master), L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned agree, as of July 11, 2022, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Provention Bio, Inc., and such statement to which this Joint Filing Agreement is attached as Exhibit 1 is filed on behalf of each of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Sessa Capital (Master), L.P. • Real estate investment trusts
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned agree, as of February 14, 2022, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Orion Office REIT Inc., and such statement to which this Joint Filing Agreement is attached as Exhibit 1 is filed on behalf of each of the undersigned.
SETTLEMENT AGREEMENTSettlement Agreement • February 17th, 2017 • Sessa Capital (Master), L.P. • Real estate investment trusts
THIS SETTLEMENT AGREEMENT (this “Agreement”) is entered into as of February 16, 2017, by and among the entities listed on Exhibit A (collectively, the “Ashford Entities”) and Sessa Capital (Master), L.P., a Cayman Islands exempted limited partnership, Sessa Capital GP, LLC, a Delaware limited liability company, Sessa Capital IM, L.P., a Delaware limited partnership, Sessa Capital IM GP, LLC, a Delaware limited liability company, and John Petry (collectively, “Sessa” and, together with the Ashford Entities, the “Parties”).
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Sessa Capital (Master), L.P. • Pharmaceutical preparations
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned agree, as of February 14, 2022, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Provention Bio, Inc., and such statement to which this Joint Filing Agreement is attached as Exhibit 1 is filed on behalf of each of the undersigned.
SCHEDULE 13GJoint Filing Agreement • November 14th, 2024 • Sessa Capital (Master), L.P. • Services-medical laboratories
Joint Filing Agreement, dated as of November 14, 2024, by and between Sessa Capital (Master), L.P., Sessa Capital GP, LLC, Sessa Capital IM, L.P., Sessa Capital IM GP, LLC, and John Petry.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2024 • Sessa Capital (Master), L.P. • Services-medical laboratories
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned agree, as of February 14, 2024, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Fortrea Holdings Inc. and such statement to which this Joint Filing Agreement is attached as Exhibit 1 is filed on behalf of each of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Sessa Capital (Master), L.P. • Life insurance
Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned agree, as of February 14, 2022, that only one statement containing the information required by Schedule 13G, and each amendment thereto, need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Jackson Financial Inc., and such statement to which this Joint Filing Agreement is attached as Exhibit 1 is filed on behalf of each of the undersigned.
JOINT FILING AGREEMENTJoint Filing Agreement • May 10th, 2021 • Sessa Capital (Master), L.P. • Motor vehicle parts & accessories
We, the undersigned, hereby express our agreement that the attached Schedule 13D is, and any further amendments thereto signed by each of the undersigned shall be, filed on behalf of us pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934. This agreement may be terminated with respect to the obligations to jointly file future amendments to such statement on Schedule 13D as to any of the undersigned upon such person giving written notice thereof to each of the other persons signatory hereto, at the principal office thereof.
